Dr. Takashi Kameda is a Senior Scientist for Biopharmaceutical Quality in the Office of Vaccines and Blood Products at the Pharmaceuticals and Medical Devices Agency (PMDA), Japan. He has been involved in the review of biologics, including blood products and biotechnology-derived products, since 2007. He currently serves as a Deputy Topic Leader and quality expert in the ICH Q1 guideline revision project.
Dr. Kameda graduated from the Faculty of Science, Tohoku University, in 1992 and received his Ph.D. from the University of Tokyo in 1997. Prior to joining PMDA, he worked in academic research and education from 1997 to 2007, including positions at Akita University School of Medicine and as a Visiting Scientist at the University of Wisconsin-Madison.
